NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $51.3 million in its second quarter.
The New York-based company said it had a loss of 99 cents per share.
The results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 99 cents per share.
The biopharmaceutical company posted revenue of $218.4 million in the period, which did not meet Street forecasts. Seven analysts surveyed by Zacks expected $224.5 million.
Axsome shares have risen 16% since the beginning of the year. The stock has more than doubled in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXSM at https://www.zacks.com/ap/AXSM
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
